Verhey FRJ - Search Results

1

Predicting progression to dementia in persons with mild cognitive impairment using cerebrospinal fluid markers.

Handels RLH, Vos SJB, Kramberger MG, Jelic V, Blennow K, van Buchem M, van der Flier W, Freund-Levi Y, Hampel H, Olde Rikkert M, Oleksik A, Pirtosek Z, Scheltens P, Soininen H, Teunissen C, Tsolaki M, Wallin AK, Winblad B, Verhey FRJ, Visser PJ. Handels RLH, et al. Among authors: verhey frj. Alzheimers Dement. 2017 Aug;13(8):903-912. doi: 10.1016/j.jalz.2016.12.015. Epub 2017 Feb 17. Alzheimers Dement. 2017. PMID: 28216393

2

Characteristics of preclinical Alzheimer's disease.

Visser PJ, Verhey FR, Ponds RW, Jolles J. Visser PJ, et al. Int J Geriatr Psychiatry. 2002 Jan;17(1):88-9. doi: 10.1002/gps.511. Int J Geriatr Psychiatry. 2002. PMID: 11802238 No abstract available.

3

Medial temporal lobe atrophy predicts Alzheimer's disease in patients with minor cognitive impairment.

Visser PJ, Verhey FR, Hofman PA, Scheltens P, Jolles J. Visser PJ, et al. J Neurol Neurosurg Psychiatry. 2002 Apr;72(4):491-7. doi: 10.1136/jnnp.72.4.491. J Neurol Neurosurg Psychiatry. 2002. PMID: 11909909 Free PMC article.

4

Diagnostic accuracy of the Preclinical AD Scale (PAS) in cognitively mildly impaired subjects.

Visser PJ, Verhey FR, Scheltens P, Cruts M, Ponds RW, Van Broeckhoven CL, Jolles J. Visser PJ, et al. J Neurol. 2002 Mar;249(3):312-9. doi: 10.1007/s004150200011. J Neurol. 2002. PMID: 11993532 Clinical Trial.

5

An economic evaluation of donepezil in mild to moderate Alzheimer's disease: results of a 1-year, double-blind, randomized trial.

Wimo A, Winblad B, Engedal K, Soininen H, Verhey F, Waldemar G, Wetterholm AL, Mastey V, Haglund A, Zhang R, Miceli R, Chin W, Subbiah P; Donepezil Nordic Study Group. Wimo A, et al. Dement Geriatr Cogn Disord. 2003;15(1):44-54. doi: 10.1159/000066669. Dement Geriatr Cogn Disord. 2003. PMID: 12457078 Clinical Trial.

6

Cognitive functioning after stroke: a one-year follow-up study.

Rasquin SM, Lodder J, Ponds RW, Winkens I, Jolles J, Verhey FR. Rasquin SM, et al. Dement Geriatr Cogn Disord. 2004;18(2):138-44. doi: 10.1159/000079193. Epub 2004 Jun 18. Dement Geriatr Cogn Disord. 2004. PMID: 15211068

7

Demographic and CT scan features related to cognitive impairment in the first year after stroke.

Rasquin SM, Verhey FR, van Oostenbrugge RJ, Lousberg R, Lodder J. Rasquin SM, et al. J Neurol Neurosurg Psychiatry. 2004 Nov;75(11):1562-7. doi: 10.1136/jnnp.2003.024190. J Neurol Neurosurg Psychiatry. 2004. PMID: 15489388 Free PMC article.

8

Predictive accuracy of MCI subtypes for Alzheimer's disease and vascular dementia in subjects with mild cognitive impairment: a 2-year follow-up study.

Rasquin SM, Lodder J, Visser PJ, Lousberg R, Verhey FR. Rasquin SM, et al. Dement Geriatr Cogn Disord. 2005;19(2-3):113-9. doi: 10.1159/000082662. Epub 2004 Dec 9. Dement Geriatr Cogn Disord. 2005. PMID: 15591801 Free article.

9

Medial temporal lobe atrophy and APOE genotype do not predict cognitive improvement upon treatment with rivastigmine in Alzheimer's disease patients.

Visser PJ, Scheltens P, Pelgrim E, Verhey FR; Dutch ENA-NL-01 Study Group. Visser PJ, et al. Dement Geriatr Cogn Disord. 2005;19(2-3):126-33. doi: 10.1159/000082883. Epub 2004 Dec 23. Dement Geriatr Cogn Disord. 2005. PMID: 15627759

10

Predictors of reversible mild cognitive impairment after stroke: a 2-year follow-up study.

Rasquin SM, Lodder J, Verhey FR. Rasquin SM, et al. J Neurol Sci. 2005 Mar 15;229-230:21-5. doi: 10.1016/j.jns.2004.11.015. Epub 2004 Dec 28. J Neurol Sci. 2005. PMID: 15760615 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

459 results

Search Page